Letter to the Editor
Unsolved issues of The Efficacy and Safety of Edoxaban
1Department of Pharmacology, Jagiellonian University Medical College, Krakow, Poland
2Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland
2Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland
Anatol J Cardiol 2021; 25(6): 460-460 DOI: 10.5152/AnatolJCardiol.2021.81410
Keywords: atrial fibrillation, bleeding, edoxaban, non-vitamin K antagonist oral anticoagulant, stroke, warfarin